Vaxcyte, Inc. SEC filings PCVX
Vaxcyte, Inc. has 767 filings in SEC EDGAR's recent list, going back to Jul 24, 2015. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 305B2 | Filing | Oct 6, 2026 | — |
| UPLOAD | Letter from the SEC | May 14, 2025 | — |
| CORRESP | Letter to the SEC | May 7, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 10, 2025 | — |
| EFFECT | Filing | Jun 11, 2020 | — |
| CERT | 8a cert | Jun 10, 2020 | — |
| 8-A12B | Filing | Jun 9, 2020 | — |
| CORRESP | Letter to the SEC | Jun 9, 2020 | — |
| CORRESP | Letter to the SEC | Jun 9, 2020 | — |
| CORRESP | Letter to the SEC | May 22, 2020 | — |
| D | Filing | Apr 3, 2020 | — |
| UPLOAD | Letter from the SEC | Mar 27, 2020 | — |
| DRSLTR | Filing | Mar 13, 2020 | — |
| DRS/A | Filing | Mar 13, 2020 | — |
| UPLOAD | Letter from the SEC | Jan 21, 2020 | — |
| DRSLTR | Filing | Dec 31, 2019 | — |
| DRS/A | Filing | Dec 31, 2019 | — |
| UPLOAD | Letter from the SEC | Nov 8, 2019 | — |
| DRS | Filing | Oct 11, 2019 | — |
| D | Filing | Jun 12, 2018 | — |
| D | Filing | Mar 21, 2017 | — |
| D | Filing | Jul 24, 2015 | — |
Showing 22 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- PCVX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Carlos, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1649094
- Former names
- SutroVax, Inc. (until Apr 3, 2020)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.